课题基金 / 基金详情

mechanism of drug resistance in breast cancer : the correlation between steroid and xenobiotic receptor (SXR) and UDP-glucuronosyltransferase (UGT)

mechanism of drug resistance in breast cancer : the correlation between steroid and xenobiotic receptor (SXR) and UDP-glucuronosyltransferase (UGT)
乳腺癌耐药机制:类固醇和异生素受体(SXR)与UDP-葡萄糖醛酸基转移酶(UGT)之间的相关性
批准号:
19790912
负责人:
ODAWARA Hiroki
金额:
$2.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Steroid and xenobiotic receptor (SXR) is ligand-activated transcription factor, which is a member of the nuclear hormone receptor superfamily. We have reported that SXR activated the expression of CYP3A4 and MDR-I, playing a part of phase I stage in drug metabolism, in breast cancer cells lines. Conjugation is the phase II stage of drug metabolism, and is catalyzed by UDP-glucuronosyltransferase (UGT). So, we investigated the correlation between SXR and UGT in breast cancer cells.We confirmed the expression of UGT1A1, UGT1A4 and UGT2B7 mRNA by RT-PCR inbreast cancer cell lines. UGT1A1 can conjugate estrogens. UGT1A4 and UGT2B7 canconjugate tamoxifen, which is the drug for hormone therapy of for breast cancer. It wasreported thatSince the expression of UGT1A1 and UGT1A4 are is regulated by SXR inhepatocellular carcinoma cell lines. W, we also studied and confirmed the up-regulation ofUGT1A4 expression by SXR in breast cancer cell lines. Furthermore, Wwe investigated theexpression levels of UGT1A1, UGT1A4 and UGT2B7 in breast cancer tissues by real-timeRT-PCR, using the specimens from 70 breast cancer patients, who were undergone theoperation in Gunma University Hospital between in 2007 and 2008. There was were nocorrelations between SXR and UGT1A1, and. There was also no correlation between SXRand UGT1A4 mRNA levels. But wWe could not measure the expression level of UGT2B7mRNA. In summary, Wwe could not obtain fund the evidence for regulation of UGT by SXRfrom this experiment plan. Because there is a fewseveral evidences of that such regulation,so we need more experiment.more study may be necessary.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
乳癌細胞におけるPCBによる核内ホルモン受容体を介する転写の活性化-
乳腺癌细胞中多氯联苯通过核激素受体激活转录
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Sajdel-Sulkowska E, Xu M, Koibuchi N, Koibuchi N, 鯉淵典之, 鯉淵典之, Koibuchi N, Koibuchi N, 岩崎俊晴, 鯉淵幸生, 鯉淵典之, 岩崎俊晴, 堀口 淳, 鯉淵幸生, 小田原宏樹, 堀口 淳, 鯉淵幸生, Koibuchi N, Koibuchi N, Koibuchi N, Iwasaki T, 小田原宏樹, 堀口 淳, 堀口 淳, 岩崎俊晴, 堀口 淳, 小田原宏樹, 堀口 淳, 堀口淳, 堀口淳, 堀口淳, 堀口淳, 堀口淳, 鯉淵幸生, 鯉淵幸生, 鯉淵幸生, 小田原宏樹, 小田原宏樹, Iwasaki T, 岩崎俊晴, 岩崎俊晴, 岩崎俊晴, 岩崎俊晴, Koibuchi N, Koibuchi N, Koibuchi N, Koibuchi N, 鯉淵典之, 岩崎俊晴, Koibuchi N, 鯉淵幸生, 鯉淵幸生, 堀口 淳, 鯉淵幸生, Koibuchi N, Koibuchi N, 堀口 淳, 鯉淵幸生, 小田原宏樹]
通讯作者: 小田原宏樹
乳癌組織における核内ホルモン受容体RORα発現の意義
乳腺癌组织中核激素受体RORα表达的意义
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [小田原宏樹, 堀口淳, 岩崎俊晴, 鯉淵幸生, 六反田奈和, 長岡りん, 時庭英彰, 樋口徹, 飯野祐一, 鯉淵典之, 竹吉泉, 小田原宏樹]
通讯作者: 小田原宏樹
Activation of Aromatase Expression by Retinoic Acid Receptor-related Orphan Receptor (ROR)αin Breast Cancer Cells: identification of a novel ROR response elementIDENTIFICATION OF A NOVEL ROR RESPONSE ELEMENT.
乳腺癌细胞中视黄酸受体相关孤儿受体 (ROR)α 激活芳香酶表达:新型 ROR 反应元件的鉴定新型 ROR 反应元件的鉴定。
DOI: --
发表时间: 2009
期刊: J Biologic Chem 284
影响因子: --
作者: [Hiroki Odawara, Toshiharu Iwasaki, Jun Horiguchi, Nana Rokutanda, Kazumi Hirooka, Wataru Miyazaki, Yukio Koibuchi, Noriaki Shimokawa, Yuichi Iino, Izumi Takeyoshi, Noriyuki Koibuchi]
通讯作者: Noriyuki Koibuchi
核内受容体RORαによる乳癌細胞増殖能の活性化
核受体RORα激活乳腺癌细胞增殖能力
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [小田原宏樹, 堀口淳, 岩崎俊晴, 鯉淵幸生, 六反田奈和, 長岡りん, 時庭英彰, 樋口徹, 飯野祐一, 鯉淵典之, 竹吉泉]
通讯作者: 竹吉泉
26
    海外基金